Verition Fund Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$969K Sell
11,186
-26,714
-70% -$2.56M 0.01% 1317
2025
Q4
$3.64M Buy
37,900
+3,558
+10% +$346K 0.01% 1114
2025
Q3
$3.27M Sell
34,342
-198,057
-85% -$18.2M 0.01% 1566
2025
Q2
$20.3M Buy
232,399
+131,642
+131% +$11.2M 0.09% 230
2025
Q1
$9.05M Sell
100,757
-137,342
-58% -$12.3M 0.04% 505
2024
Q4
$19M Buy
238,099
+132,365
+125% +$11.5M 0.08% 255
2024
Q3
$9.52M Buy
105,734
+22,156
+27% +$1.86M 0.05% 424
2024
Q2
$6.58M Sell
83,578
-13,314
-14% -$1.09M 0.04% 561
2024
Q1
$8.44M Buy
96,892
+78,534
+428% +$6.7M 0.06% 395
2023
Q4
$1.51M Sell
18,358
-22,408
-55% -$1.71M 0.01% 978
2023
Q3
$3.19M Buy
40,766
+14,274
+54% +$1.19M 0.04% 605
2023
Q2
$2.33M Buy
26,492
+3,343
+14% +$288K 0.03% 616
2023
Q1
$1.87M Sell
23,149
-91,648
-80% -$7.47M 0.03% 719
2022
Q4
$8.92M Buy
114,797
+47,906
+72% +$3.88M 0.14% 178
2022
Q3
$5.4M Buy
66,891
+30,406
+83% +$2.73M 0.06% 381
2022
Q2
$3.27M Buy
+36,485
New +$3.7M 0.06% 415
2022
Q1
Sell
-50,247
Closed -$5.31M 2900
2021
Q4
$5.2M Sell
50,247
-9,264
-16% -$1.07M 0.04% 343
2021
Q3
$7.46M Buy
59,511
+51,758
+668% +$6.7M 0.06% 197
2021
Q2
$962K Sell
7,753
-624
-7% -$78.3K 0.01% 820
2021
Q1
$990K Buy
8,377
+2,862
+52% +$335K 0.01% 615
2020
Q4
$646K Sell
5,515
-29,182
-84% -$3.21M 0.01% 601
2020
Q3
$3.61M Buy
34,697
+18,848
+119% +$1.89M 0.07% 163
2020
Q2
$1.45M Sell
15,849
-11,458
-42% -$1.1M 0.05% 300
2020
Q1
$2.46M Buy
27,307
+7,824
+40% +$832K 0.1% 142
2019
Q4
$2.21M Buy
19,483
+14,799
+316% +$1.62M 0.04% 255
2019
Q3
$509K Sell
4,684
-66,867
-93% -$6.98M 0.01% 620
2019
Q2
$6.97M Buy
71,551
+28,089
+65% +$2.56M 0.2% 86
2019
Q1
$3.96M Buy
43,462
+27,732
+176% +$2.48M 0.15% 98
2018
Q4
$1.43M Sell
15,730
-22,194
-59% -$2.07M 0.1% 182
2018
Q3
$3.73M Buy
37,924
+23,133
+156% +$2.14M 0.13% 140
2018
Q2
$1.27M Sell
14,791
-29,791
-67% -$2.49M 0.08% 324
2018
Q1
$3.58M Buy
44,582
+1,579
+4% +$130K 0.27% 64
2017
Q4
$3.47M Sell
43,003
-688
-2% -$55.1K 0.32% 55
2017
Q3
$3.4M Buy
43,691
+7,846
+22% +$651K 0.27% 64
2017
Q2
$3.18M Sell
35,845
-26,443
-42% -$2.23M 0.31% 55
2017
Q1
$5.02M Sell
62,288
-19,308
-24% -$1.51M 0.47% 28
2016
Q4
$5.81M Buy
81,596
+76,767
+1,590% +$6.03M 0.5% 21
2016
Q3
$417K Buy
4,829
+1,491
+45% +$130K 0.04% 585
2016
Q2
$290K Sell
3,338
-13,062
-80% -$1.06M 0.04% 614
2016
Q1
$1.23M Buy
16,400
+13,528
+471% +$1.02M 0.2% 109
2015
Q4
$221K Sell
2,872
-17,156
-86% -$1.29M 0.04% 369
2015
Q3
$1.34M Sell
20,028
-2,152
-10% -$158K 0.35% 63
2015
Q2
$1.64M Buy
+22,180
New +$1.69M 0.29% 60
2014
Q4
Sell
-7,390
Closed -$458K 535
2014
Q3
$458K Buy
7,390
+1,886
+34% +$120K 0.06% 261
2014
Q2
$351K Sell
5,504
-14,914
-73% -$906K 0.04% 363
2014
Q1
$1.26M Buy
20,418
+12,305
+152% +$717K 0.19% 83
2013
Q4
$466K Buy
+8,113
New +$460K 0.08% 190
2013
Q3
Sell
-13,252
Closed -$682K 638
2013
Q2
$682K Buy
+13,252
New +$655K 0.13% 156

Other funds holding MDT

Verition Fund Management's MDT Position: Q1 2026 in Review

Verition Fund Management reduced its Medtronic (MDT) stake by 70% in Q1 2026, selling an estimated $2.56M and leaving 11,186 shares worth $969K. The position accounts for 0.01% of the portfolio, ranked #1317.

Verition Fund Management first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $20.3M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Verition Fund Management held 11,186 shares of Medtronic worth $969K as of Q1 2026.
  • Verition Fund Management sold 26,714 Medtronic shares in Q1 2026, an estimated $2.56M.
  • Medtronic made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1317 holding.
  • Verition Fund Management first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • Verition Fund Management's Medtronic position peaked at $20.3M in Q2 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.